Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06412991 · ClinicalTrials.gov registry record · NA

Pedal Movement - Implementing Cycling as a Mobility Option

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
76
Enrollment target

NCT06412991: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT06412991 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06412991, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target

Study Summary

Cycling has been a proven exercise for decades as a low impact option to strengthen the lower body and improve cardiovascular health. There is also evidence that cycling helps to stimulate the contraction of the muscles in the intestine. Other outcomes frequently examined when considering benefits of ambulation include decreased rates of venous thromboembolic events, pneumonia, and decreased hospital length of stays. Therefore, there is added value to consider alternate mobility modalities.

Primary Outcome

Length of time to first Bowel Movement

Interventions

  • BEHAVIORAL Cycle Therapy

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2024-08-20
Est. Completion 2025-02-03
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT06412991 record still lists

NCT06412991 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Cycle Therapy is the first listed.

NCT06412991 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06412991 about?

NCT06412991 is a clinical study titled "Pedal Movement - Implementing Cycling as a Mobility Option". Cycling has been a proven exercise for decades as a low impact option to strengthen the lower body and improve cardiovascular health. There is also evidence that cycling helps to stimulate the contraction of the muscles in the intestine. Other outcomes frequently examined when considering benefits o...

What is the current status of trial NCT06412991?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2024-08-20. Estimated completion is 2025-02-03.

What interventions are being tested in trial NCT06412991?

The interventions under investigation include: Cycle Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06412991?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06412991's enrollment target sits among peer trials

76 1062nd of 2000 higher than 932 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06412991, the US trial registry maintained by the National Library of Medicine. NCT06412991 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.